[
  {
    "ts": null,
    "headline": "New Survey Offers Important Insights into How Medicare Advantage Beneficiaries Use and Value Their Supplemental Benefits",
    "summary": "LOUISVILLE, Ky., November 20, 2025--A recent study conducted by Humana Healthcare Research, with strategic input from researchers at the University of Pennsylvania, reveals key insights into how Medicare Advantage beneficiaries perceive and engage with their supplemental benefits. Results indicate the majority of respondents highly value the benefits they use and agreed supplemental benefits could improve health and save individuals money.",
    "url": "https://finnhub.io/api/news?id=6f2c7a00588002f1f69fb07961d620a9b01c35d4ad8245200d5eeff20d1a74f5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763647200,
      "headline": "New Survey Offers Important Insights into How Medicare Advantage Beneficiaries Use and Value Their Supplemental Benefits",
      "id": 137556788,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "LOUISVILLE, Ky., November 20, 2025--A recent study conducted by Humana Healthcare Research, with strategic input from researchers at the University of Pennsylvania, reveals key insights into how Medicare Advantage beneficiaries perceive and engage with their supplemental benefits. Results indicate the majority of respondents highly value the benefits they use and agreed supplemental benefits could improve health and save individuals money.",
      "url": "https://finnhub.io/api/news?id=6f2c7a00588002f1f69fb07961d620a9b01c35d4ad8245200d5eeff20d1a74f5"
    }
  },
  {
    "ts": null,
    "headline": "Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer",
    "summary": "HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed a national agreement with Humana, Inc. (NYSE: HUM), effective October 29, 2025, covering approximately 16 million people throughout the United States, to provide the CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) laboratory developed test (LDT). This brings CNSide CSF TCE LDT total pol",
    "url": "https://finnhub.io/api/news?id=1533af78043222e47be9802205772cabef8491e7fa51d6ef64f8cd98bc34004e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763641800,
      "headline": "Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer",
      "id": 137556789,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed a national agreement with Humana, Inc. (NYSE: HUM), effective October 29, 2025, covering approximately 16 million people throughout the United States, to provide the CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) laboratory developed test (LDT). This brings CNSide CSF TCE LDT total pol",
      "url": "https://finnhub.io/api/news?id=1533af78043222e47be9802205772cabef8491e7fa51d6ef64f8cd98bc34004e"
    }
  },
  {
    "ts": null,
    "headline": "U.S. Managed Care Q3 2025 Earnings Recap: Costs Grow As ACA Worries Loom",
    "summary": "US managed care insurers' Q3 earnings season was characterized by higher medical costs amid political uncertainty surrounding extensions of the Affordable Care Act tax credits.",
    "url": "https://finnhub.io/api/news?id=4166df4456f096b12829fc5b9c1f6487e2ab14bae2550cb0ff6fb4dffbe536b4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763606400,
      "headline": "U.S. Managed Care Q3 2025 Earnings Recap: Costs Grow As ACA Worries Loom",
      "id": 137552789,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2181984747/image_2181984747.jpg?io=getty-c-w1536",
      "related": "HUM",
      "source": "SeekingAlpha",
      "summary": "US managed care insurers' Q3 earnings season was characterized by higher medical costs amid political uncertainty surrounding extensions of the Affordable Care Act tax credits.",
      "url": "https://finnhub.io/api/news?id=4166df4456f096b12829fc5b9c1f6487e2ab14bae2550cb0ff6fb4dffbe536b4"
    }
  }
]